Federal contractors / DYNPORT VACCINE COMPANY LLC

Federal contract award

W911QY13C0056

PROGRAM REPORTING - TECHNICAL

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeW6QK ACC-APG
NAICS541711
PSC6505 — Drugs and Biologicals
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS FIXED FEE
Obligations$117.6M
Current contract value$257.4M
Potential contract value / ceiling$258.1M
Start dateMay 9, 2013
Current end dateMar 11, 2027
Potential end dateMar 11, 2027
Latest award activityMay 12, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 84 of 84 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
May 12, 2026P00083$0TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Apr 16, 2026P00082$0TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Mar 26, 2026P00081$0TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Sep 12, 2025P00080$-316.9KTERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Jul 25, 2025P00079$0EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 12 MARCH 2026 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Mar 13, 2024P00078$0EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 14 MARCH 2024 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS.
Mar 31, 2023P00077$0EXTEND DEADLINE FOR TERMINATION SETTLEMENT PROPOSAL SUBMISSION DATE TO 14 MARCH 2024 UNDER TERMINATED CONTRACT FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLAXIS
Mar 9, 2022P00076$0ADMIN ACTION TO EXTEND TERMINATION SETTLEMENT PROPOSAL DEADLINE FOR FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Mar 4, 2021P00075$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA - ADMIN MODIFICATION
Aug 8, 2019P00074$-7.7MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Aug 5, 2019P00073$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
May 24, 2019P00072$-5.5MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Apr 4, 2019P00071$11.2MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Sep 25, 2018P00070$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Sep 21, 2018P00069$4.4MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jul 27, 2018P00068$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jul 26, 2018P00067$637.6KFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jun 26, 2018P00066$6.6KFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
May 25, 2018P00065$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
May 18, 2018P00064$1.5MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Feb 16, 2018P00063$2.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jan 25, 2018P00062$500.0KFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Dec 28, 2017P00061$-4.8MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Dec 20, 2017P00060$5.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Nov 29, 2017P00059$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Oct 27, 2017P00058$4.8MIGF::OT::IGF
Oct 15, 2017P00057$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Sep 28, 2017P00056$3.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Sep 12, 2017P00055$2.7MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Aug 10, 2017P00054$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jul 25, 2017P00053$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jun 30, 2017P00052$4.1MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
May 19, 2017P00051$1.8MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
May 10, 2017P00050$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Mar 28, 2017P00049$1.2MIGF::OT::IGF
Feb 28, 2017P00047$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Feb 28, 2017P00048$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Feb 27, 2017P00046$4.4MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jan 19, 2017P00045$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jan 9, 2017P00044$9.0MINCREMENTAL FUNDING MOD.
Dec 28, 2016P00043$-5.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Nov 28, 2016P00042$1.5MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Aug 25, 2016P00040$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Aug 25, 2016P00041$6.4MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Aug 1, 2016P00039$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jul 28, 2016P00038$1.8MINCREMENTAL FUNDING
May 17, 2016P00037$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA - POP EXTENSION
Apr 28, 2016P00036$2.0MFUNDING ONLY MODIFICATION
Apr 5, 2016P00035$0ATP MODIFICATION
Mar 29, 2016P00034$10.1MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Mar 22, 2016P00033$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Mar 15, 2016P00032$0ADD NONCLINICAL STRATEGY
Feb 1, 2016P00031$7.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jan 26, 2016P00030$5.6MAUTHORIZATION TO PROCEED - NON-CLINICAL STUDIES
Jan 8, 2016P00029$2.5MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jan 6, 2016P00028$0FDA PROPHALAXIS
Dec 21, 2015P00027$1.5MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Dec 8, 2015P00026$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Nov 17, 2015P00025$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Oct 26, 2015P00024$6.9MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Oct 23, 2015P00023$0FILTER PRESS FRAME PURCHASE FOR PRODUCT MANUFACTURING
Oct 15, 2015P00022$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Sep 15, 2015P00021$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Sep 10, 2015P00020$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Aug 18, 2015P00019$-7.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jun 29, 2015P00018$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jun 19, 2015P00017$-3.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
Jun 4, 2015P00016$-7.0MFDA LICENSURE OF A BIOSCAVENGER PROPHYLA
May 28, 2015P00015$0FDA LICENSURE OF A BIOSCAVENGER PROPHYLA
May 13, 2015P00014$0DEVELOPMENT AND FDA LICENSURE OF BIOSCAVENGER
Apr 20, 2015P00013$3.0MINCREMENTAL FUNDING
Mar 4, 2015P00012$0BIOSCAVENGER
Feb 24, 2015P00011$17.0MPROGRAM REPORTING - TECHNICAL
Nov 17, 2014P00010$4.5MPROGRAM REPORTING - TECHNICAL
Oct 16, 2014P00009$-8.0MPROGRAM REPORTING - TECHNICAL
Sep 8, 2014P00008$48.1KINCREMENTAL FUNDS MOD
May 5, 2014P00007$3.8MINCREMENTAL FUNDING MOD
Mar 25, 2014P00006$15.0MINCREMENTAL FUNDS
Jan 16, 2014P00005$0DEVELOPMENT AND FDA LICENSURE OF BIOSCAVENGER
Nov 26, 2013P00004$5.4MDEVELOPMENT AND FDA LICENSURE OF BIOSCAVENGER
Sep 30, 2013P00003$0BIOSCAVENGER
Aug 23, 2013P00002$2.7MPROGRAM REPORTING - TECHNICAL
Jun 21, 2013P00001$0BIOSCAVENGER
May 9, 20130$12.9MPROGRAM REPORTING - TECHNICAL

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
65/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 65/100. Available recorded signals: 60 points.

Contract end 2027-03-11 (130 days from calculation)
+35 points
1 historical awards in this buyer and category group
+0 points
84 recorded award transactions
+10 points
Latest award action: 2026-05-12
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.